Magic of a Common Sugar Pill in Cancer: Can Metformin Raise Survival in Pancreatic Cancer Patients?

Pancreatic cancer is one of the common cancers globally, with a poor survival outcome. Metformin, a popular anti-diabetic drug, has gained popularity for its use in the chemoprevention of cancer. However, results regarding the survival benefit of metformin in pancreatic cancer have been unpredictabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Gyawali, Mallika, Venkatesan, Nanditha, Ogeyingbo, Opemipo D, Bhandari, Renu, Botleroo, Rinky A, Kareem, Roaa, Ahmed, Rowan, Elshaikh, Abeer O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343553/
https://www.ncbi.nlm.nih.gov/pubmed/34367843
http://dx.doi.org/10.7759/cureus.16916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343553/
https://www.ncbi.nlm.nih.gov/pubmed/34367843
http://dx.doi.org/10.7759/cureus.16916

Ejemplares similares